© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
Urology Times staff
Articles
Dr. Galsky explains results of pivotal adjuvant immunotherapy trials in urothelial cancer
December 03, 2022
Video
Matthew Galsky, MD, discusses the discordant results of the pivotal phase 3 CheckMate-274 and IMvigor010 trials of adjuvant immunotherapy in urothelial cancer.
Dr. Hannan on role of stereotactic radiotherapy for kidney cancer in community setting
December 03, 2022
Video
Raquibul Hannan, MD, PhD, describes patients with renal cell carcinoma who may be appropriate for treatment with stereotactic radiotherapy.
Dr. Laura Sena discusses bipolar androgen therapy for prostate cancer
December 02, 2022
Video
“This is different from other standard-of-care therapies for prostate cancer because usually we are inhibiting androgen receptor (AR) activity and here we’re actually stimulating AR,” explained Laura Anne Sena, MD, PhD.
Dr. Galsky explains the biomarker challenge with adjuvant immunotherapy in urothelial cancer
December 02, 2022
Video
“In the adjuvant setting, we have a ‘double biomarker problem.’ Not only don’t we know which drugs work best in which patients, we actually don’t even know which patients need additional systemic treatment because many patients are already cured with surgery,” says Matthew Galsky, MD.